(ABT Alert) Long Term Holders of Abbott Laboratories Contact Johnson Fistel for Information Regarding Investigation
SAN DIEGO, March 24, 2022 (GLOBE NEWSWIRE) — Johnson Fistel, LLP is investigating potential breaches of fiduciary duty/or violations of federal and/or state law on behalf of Abbott Laboratories (“Abbott” or the “Company”) (NYSE: ABT) against certain of its officers and directors.
Recently the Food and Drug Administration inspectors found unsanitary conditions at an Abbott Laboratories plant in Michigan that makes infant formula. The finding was made five months before the Company conducted a recall of products associated with the deaths of two babies.
If you are a current, long-term shareholder of Abbott holding shares before September 2019, you may have standing to hold Abbott harmless from the alleged harm caused by the Company’s officers and directors by making them personally responsible. You may also be able to assist in reforming the Company’s corporate governance to prevent future wrongdoing.
To join this action, you can click or copy and paste the link below: https://www.cognitoforms.com/JohnsonFistel/AbbottLaboratories
Follow us on Twitter: Here
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. Johnson Fistel seeks to recover losses incurred due to violations of federal securities laws. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.
Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
[email protected]
Disclaimer: This content is distributed by The GlobeNewswire
